Athersys, Inc. Receives Orphan Drug Designation for MultiStem in Hurler's Syndrome
Join the discussion below, or Read more at BioSpace.
#1 Jul 11, 2012
any idea when a partnership for this is happening??? Don;t wish to see another dilution exercise.
#2 Jul 17, 2012
I'm starting to loose patience at Athersys. Whenever there's slightest bit of positive news, this damn stock will go down and remain down.
Add your comments below
|Obama asks Congress for $1.8 billion to fight Zika||21 hr||Guru||11|
|Premature Ejaculation Drug (Jul '06)||Jan 31||Dr Wu||33|
|Drugmaker Pfizer sees profit gain after acquisi... (May '10)||Jan 31||Noell||18|
|Vivus Wins FDA Approval (Aug '12)||Jan 31||Tara||13|
|Earnings Preview: Pfizer to report 2Q earnings (Aug '10)||Jan 31||Sharolyn||18|
|Q1 2016 EPS Estimates for McKesson Co. (MCK) De...||Jan 30||Syntax Error||1|
|Bristol-Myers Squibb Co (BMY) Stake Raised by B...||Jan 30||Syntax Error||1|
Find what you want!
Search Biotech Forum Now
Copyright © 2016 Topix LLC